Study Details

Study ID 1941-CL-0004
Study Title A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects with Type 2 Diabetes Mellitus Identifier NCT01071850
Compound Name ASP1941 / ipragliflozin
Medical Indication or Disease Type 2 diabetes mellitus
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Not Applicable
Study Start Date 03-Mar-2010
Study Completion Date 11-Apr-2011
Clinical Study Result
Select the language
Plain Language Summary
Select the language